Larvol Delta - ALS-CervoMed-expects-initiation-of-the-EXPERTSALS-trial-evaluating-neflamapimod-in-patients-with-ALS-by-the-end-of-2026

neflamapimod (VX-745) - CervoMed

https://www.globenewswire.com/news-release/2026/03/17/3257039/0/en/CervoMed-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-Corporate-Updates.html

Mar 17, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next